Viewing Study NCT06025695


Ignite Creation Date: 2025-12-24 @ 2:11 PM
Ignite Modification Date: 2025-12-27 @ 9:32 PM
Study NCT ID: NCT06025695
Status: COMPLETED
Last Update Posted: 2025-05-09
First Post: 2023-08-29
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix Porcine Circovirus (PCV)-Free Liquid Compared to Rotarix Liquid Given in 2-doses in Healthy Chinese Infants Starting at Age 6-16 Weeks
Sponsor: GlaxoSmithKline
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-09-01
Start Date Type: ACTUAL
Primary Completion Date: 2024-05-28
Primary Completion Date Type: ACTUAL
Completion Date: 2024-10-23
Completion Date Type: ACTUAL
First Submit Date: 2023-08-29
First Submit QC Date: None
Study First Post Date: 2023-09-06
Study First Post Date Type: ACTUAL
Results First Submit Date: 2025-04-23
Results First Submit QC Date: None
Results First Post Date: 2025-05-09
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-04-23
Last Update Post Date: 2025-05-09
Last Update Post Date Type: ACTUAL